Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis

Spinal Disorders

Aortic-vertebral interaction in ankylosing spondylitis: syndesmophyte development at the juxta-aortic vertebral rim

Ann Rheum Dis.

Tan S, Dasgupta A, Flynn JA, Ward MM

doi: 10.1136/

Spinal Disorders

Factors Predictive of Radiographic Progression in Ankylosing Spondylitis

Arthritis Care Res (Hoboken).

Sari I, Lee S, Tomlinson G, Johnson SR, Inman RD, Haroon N

doi: 10.1002/acr.24104.

Melanoma and Skin Cancer

Monthly changes in serum levels of S100B protein as a predictor of metastasis development in high-risk melanoma patients

J Eur Acad Dermatol Venereol.

Ertekin SS, Podlipnik S, Ribero S, Molina R, Rios J, Carrera C, Malvehy J, Puig S

doi: 10.1111/jdv.16212.

RECOMMENDED

Spinal Disorders

The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis

Semin Arthritis Rheum.

Baraliakos X, Szumski A, Koenig AS, Jones H

doi: 10.1016/j.semarthrit.

Spinal Disorders

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable

Rheumatology (Oxford).

Ortolan A, Ramiro S, van Gaalen F, Kvien TK, Landewe RBM, Machado PM, Ruyssen-Witrand A, van Tubergen A, Bastiaenen C, van der Heijde D

doi: 10.1093/rheumatology/keaa241.

Melanoma and Skin Cancer

Assessment of Deep Learning Using Nonimaging Information and Sequential Medical Records to Develop a Prediction Model for Nonmelanoma Skin Cancer

JAMA Dermatol.

Wang HH, Wang YH, Liang CW, Li YC

doi: 10.1001/jamadermatol.2019.2335.

Rheumatoid Arthritis

IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis

Mod Rheumatol.

Takasugi K, Nishida K, Natsumeda M, Yamashita M, Yamamoto W, Ezawa K

doi: 10.1080/14397595.

Psoriasis

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

JAMA Dermatol

Elewski BE, Baddley JW, Deodhar AA, Magrey M, Rich PA, Soriano ER, Soung J, Bao W, Keininger D, Marfo K, Patekar M, Sharma A, Shete A, Lebwohl MG

doi: 10.1001/jamadermatol.2020.3257

Spinal Disorders

Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis

Arthritis Res Ther.

Klasen C, Meyer A, Wittekind PS, Waqué I, Nabhani S, Kofler DM

doi: 10.1186/s13075-019-

Related content

Aortic-vertebral interaction in ankylosing spondylitis: syndesmophyte development at the juxta-aortic vertebral rim

Factors Predictive of Radiographic Progression in Ankylosing Spondylitis

Monthly changes in serum levels of S100B protein as a predictor of metastasis development in high-risk melanoma patients

The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable

Assessment of Deep Learning Using Nonimaging Information and Sequential Medical Records to Develop a Prediction Model for Nonmelanoma Skin Cancer

IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis